Epidemia diabete: nel Lazio negli anni del Covid 1260 casi in più
(Adnkronos) - Accesso alle cure: le Asl periferiche meglio dell’area metropolitana Due ore di Tv, l’uso intensivo del cellulare, la solitudine, l...
Ascend to further increase prices on nylon polymers, compounds and monomers
(Adnkronos) - HOUSTON, Oct. 19, 2023 /PRNewswire/ -- Ascend Performance Materials, the largest fully integrated producer of nylon 6,6, announced anoth...
European Organisation for Research and Treatment of Cancer & the Menarini Group Launch New Clinical Trial in Early-Stage Breast Cancer
(Adnkronos) - BRUSSELS and FLORENCE, Italy, Oct. 19, 2023 /PRNewswire/ -- The European Organisation for Research and Treatment of Cancer (EORTC) and ...
Artprice by Artmarket.com congratulates the artist Tarik Kiswanson, winner of the 2023 Marcel Duchamp Prize, sponsored by ADIAF
(Adnkronos) - PARIS, Oct. 19, 2023 /PRNewswire/ -- Dedicated to the international promotion of the French contemporary art scene, the Marcel Duchamp P...
Data Revenue continues double-digit growth momentum
(Adnkronos) - Data Revenue grows at 14.4% YoY I Digital Portfolio grows +30.2% YoY MUMBAI, India, Oct. 19, 2023 /PRNewswire/ -- Tata Communications, ...
Q3-2023 Performance to be Stronger than Expected
(Adnkronos) - Robust Demand and Significantly Improved Operational Efficiencies Drive Strong Financial Performance TORONTO and GATINEAU, QC, Oct. 1...
Synthetic Data Summit 2023 highlights progress, practical applications, and potential of synthetic health data
(Adnkronos) - OTTAWA, ON, Oct. 19, 2023 /PRNewswire/ -- Replica Analytics Ltd., an Aetion® company, and the University of Ottawa, are set to co-host...
Ugreen svela le soluzioni di alimentazione e l'archiviazione dei dati personali al Gitex Trade Show degli Emirati Arabi Uniti.
(Adnkronos) - PECHINO, 18 ottobre 2023 /PRNewswire/ -- Ugreen, leader nel settore della ricarica per elettronica e accessori, sta ampliando la propria...
SK pharmteco to showcase its extensive APIs and CGT capabilities in CPHI 2023
(Adnkronos) - RANCHO CORDOVA, Calif. and KING OF PRUSSIA, Pa., Oct. 18, 2023 /PRNewswire/ -- SK pharmteco will participate at the CPHI 2023 in Barcel...
Currax Pharmaceuticals: CONTRAVE®/MYSIMBA® demonstrates no increased risk in major adverse cardiac events in a large, long-term real-world evidence study
(Adnkronos) - BRENTWOOD, Tenn., Oct. 18, 2023 /PRNewswire/ -- Currax Pharmaceuticals LLC ("Currax") today announced top-line results from a Cardiovas...
Sei a pagina 431 |